Adage Capital Partners’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $4.45M | Hold |
|
|||||
|
2024
Q2 | $10.7M | Hold |
|
|||||
|
2024
Q1 | $11.1M | Hold |
|
|||||
|
2023
Q4 | $16.1M | Buy |
|
|||||
|
2023
Q3 | $2.85M | Hold |
|
|||||
|
2023
Q2 | $2.27M | Hold |
|
|||||
|
2023
Q1 | $1.93M | Hold |
|
|||||
|
2022
Q4 | $2.59M | Hold |
|
|||||
|
2022
Q3 | $4.65M | Buy |
|
|||||
|
2022
Q2 | $1.83M | Hold |
|
|||||
|
2022
Q1 | $2.26M | Hold |
|
|||||
|
2021
Q4 | $6.19M | Buy |
|
|||||
|
2021
Q3 | $8.05M | Buy |
|
|||||
|
2021
Q2 | $4.64M | Buy |
|